Neopterin

Primer on Certain Elements of Medical Decision Making

1975 • 1,168 citations

Immunodiagnosis of Cancer.

1980 • 163 citations

Use of receiver operating characteristic curves to evaluate the clinical performance of analytical systems.

1981 • 134 citations

Practical Haematology

1964 • 80 citations

Urinary excretion levels of unconjugated pterins in cancer patients and normal individuals

1981 • 67 citations

A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma

1984 • 65 citations

Diagnosis of Liver Diseases by Laboratory Results and Discriminant Analysis Identification of Best Combinations of Laboratory Tests

1975 • 62 citations

The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies

1985 • 53 citations

Discriminant Analysis in Clinical Chemistry

1975 • 40 citations

Pteridines in the Assessment of Neoplasia

1982 • 25 citations

A retrospective study of serial CEA determinations in the early detection of recurrent colorectal cancer

1981 • 24 citations

Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.

1982 • 24 citations

Determination of Tissue Polypeptide Antigen (TPA) Levels in Different Cancer Types and Controls

1985 • 21 citations

Urinary neopterine excretion in patients with genital cancer

1982 • 21 citations

Comparison of the tumor markers CEA, TPA, and CA 19-9 in colorectal carcinoma

1987 • 21 citations

Neopterin, ein neuer biochemischer Marker zur klinischen Erfassung zellulärer Immunreaktionen

1984 • 20 citations

Neopterin, a biochemical indicator of cellular immune reactions, in the detection and control of patients with neoplastic diseases.

1985 • 16 citations

Vergleich der Tumormarker CEA und CA 19-9 in der kolorektalen Diagnostik

2008 • 16 citations

[Key role of the CEA test in the diagnosis and surgical therapy of recurrent colorectal cancer].

1986 • 15 citations

Serum levels of prostatic acid phosphatase (PAP), tissue polypeptide antigen (TPA), CA-50, neopterine and of osteocalcin in patients with prostatic carcinoma.

1985 • 3 citations